Paul Gunn
Oprichter bij Soricimed Biopharma, Inc.
Profiel
Paul Gunn founded Soricimed Biopharma, Inc. in 2005, where he is working as President from 2019.
Mr. Gunn also formerly worked at Whitehill Technologies, Inc., as Vice President-Finance & Administration.
Actieve functies van Paul Gunn
Bedrijven | Functie | Begin |
---|---|---|
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Oprichter | 01-01-2005 |
Eerdere bekende functies van Paul Gunn
Bedrijven | Functie | Einde |
---|---|---|
Whitehill Technologies, Inc.
Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Whitehill Technologies, Inc.
Whitehill Technologies, Inc. Information Technology ServicesTechnology Services Whitehill Technologies, Inc. develops document composition and data transformation software. It develops software that accelerates business communication by automating document creation, workflow, and compliance. The company was founded in 1997 and is headquartered in Moncton, Canada. | Technology Services |
Soricimed Biopharma, Inc.
Soricimed Biopharma, Inc. BiotechnologyHealth Technology Soricimed Biopharma, Inc. develops novel cancer therapeutics and diagnostics. Its programs include SOR-C13 and Peptide-Drug Conjugate. The company was founded by Jack Stewart and Paul Gunn in 2005 and is headquartered in Moncton, Canada. | Health Technology |